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Background: A number of cellular- and molecular-level studies of autophagy assessment
have been carried out with the help of various biochemical and morphological indices.
Still there exists ambiguity for the assessment of the autophagy status and of the causal
relationship between autophagy and related cellular changes. To circumvent such
difficulties, we probe new quantitative indices of autophagy which are important for
defining autophagy activation and further assessing its roles associated with
different physiopathological states.
Methods: Our approach is based on the minimal autophagy model that allows us
to understand underlying dynamics of autophagy from biological experiments.
Specifically, based on the model, we reconstruct the experimental context-specific
autophagy profiles from the target autophagy system, and two quantitative indices
are defined from the model-driven profiles. The indices are then applied to the
simulation-based analysis, for the specific and quantitative interpretation of the system.
Results: Two quantitative indices measuring autophagy activities in the induction of
sequestration fluxes and in the selective degradation are proposed, based on the
model-driven autophagy profiles such as the time evolution of autophagy fluxes, levels
of autophagosomes/autolysosomes, and corresponding cellular changes. Further, with
the help of the indices, those biological experiments of the target autophagy system
have been successfully analyzed, implying that the indices are useful not only for
defining autophagy activation but also for assessing its role in a specific and
quantitative manner.
Conclusions: Such quantitative autophagy indices in conjunction with the computer-
aided analysis should provide new opportunities to characterize the causal relationship
between autophagy activity and the corresponding cellular change, based on the
system-level understanding of the autophagic process at good time resolution,
complementing the current in vivo and in vitro assays.
Keywords: Autophagy, Quantitative indices, Minimal autophagy model,
Computer simulationsBackground
Macroautophagy (hereafter referred to as autophagy) is a key homeostatic mechanism
for the turnover of such intracellular components as proteins/organelles [1], and is fur-
ther related to various human diseases such as cancer, metabolic disorders, and neuro-
degenerative diseases [2-7]. This has brought forth a number of physiological and
molecular-level studies of autophagy in the last decades.© 2014 Han et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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into representative metabolic/energy precursor molecules, amino acids and ATP, which
can be used as new building blocks and energy sources, respectively. Specifically, the
autophagic process begins with the formation of initial double-membrane structures
called autophagosomes containing sequestered proteins/organelles. Then the autopha-
gosomes fuse with endosomes/lysosomes to form autolysosomes. Finally, the contents
engulfed in the autolysosomes are hydrolyzed via intralysosomal hydrolysis.
The operation mechanism of the process is extremely complex. The three consecu-
tive steps, i.e., autophagosome formation, autolysosome formation, and intralysosomal
hydrolysis, are operated independently, exhibiting qualitatively/quantitatively different
responses to different intra- or extra-cellular perturbations. Hence, assessment of the
autophagy activity via specific markers such as autophagosomes and autolysosomes
often leads to under-/over-estimation of the autophagy activity. For example, as re-
vealed in experiment [8], if the rate of autolysosome formation exceeds that of autopha-
gosome formation, the steady-state concentration of autophagosomes could be
detected less, leading to an underestimation of the autophagy status. Moreover, the au-
tophagic process is regulated by the complex positive–negative feedback mechanism
(see Figure 1): The output of the process, i.e., recycled amino acids and ATP, acts as
the input of the system, which independently manipulates each of the steps in a
concentration-dependent manner [9-14]. Such feedback loops may be beneficial for the
delicate balance of the cellular homeostasis. In the perspective of causality analysis/Figure 1 Schematic representation of the model system and quantitative indices. The model
assumes a three-compartment description of the autophagic process: protein/organelle, autophagosome,
and autolysosome compartments. Solid and dotted arrows denote the autophagic feedback loops among
the compartments and non-autophagic degradation, respectively. The autophagy-related rates, including
protein/organelle synthesis RS(CA, Ca), autophagosome formation Rg1(CA, Ca) and Rg2(CA, Ca), autolysosome
formation Rl(CA), intralysosomal hydrolysis Rh(CA), and non-autophagic degradation Rd1 and Rd2 are described
in Appendix A. Dashed arrows indicate the quantitative indices fc, ΦS, and ΦI of protein/organelle quality,
autophagy selectivity, and autophagy induction, respectively.
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lationship between the autophagy activity and the concomitant cellular change.
Even if those uncertainties in the assessment of the status and causality of autophagy
are removed, there still remains ambiguity as to the roles of autophagy in the human
disease since autophagy exhibits dual effects on the development and progression of
various human diseases in a context- and activation-degree-dependent manner. Espe-
cially, autophagy plays a dual role in the tumor cell viability [15]: In some cases autoph-
agy prevents or suppresses tumor progression whereas in other cases autophagy can
also accelerate tumorigenesis or promote the survival of tumor cells. Under energy-
deficient conditions, autophagy is usually activated for the rapid supply of essential en-
ergy/metabolites to promote cell survival. In contrast, it is not rare that induced au-
tophagy contributes to apoptosis/necrosis under various cellular perturbations other
than the energy deficiency. Accordingly, it is intriguing to interpret the newly eluci-
dated mechanism of autophagy: whether the induction of autophagy contributes to the
prevention of the disease and how it works. In particular, evolutionally new molecular-
level studies sometimes contradict existing studies.
Based on the recent molecular- and physiological-level studies of the mechanism and
the role of autophagy in the human disease, on the other hand, there is research being
carried out on the development of the treatment methods or drugs that can potentially
regulate or control autophagy [16-19]. In view of these, it is very desirable to develop
specific and quantitative indices based on adequate mathematical model which could
provide a set of reliable criteria for defining the autophagy status and further the kinet-
ics of the process. To date, various indices based on biochemical [20-25] and morpho-
logical methods [26-30] for the detection of the autophagic sequestration of proteins/
organelles and for the measurement of the turnover of autophagic compartments and/
or autophagy-related markers have been developed for the assessment of autophagy.
However, those indices are not quite satisfactory for the specific and quantitative as-
sessment of the autophagy pathway as well as the system-level interpretation of the
process, especially in mammalian cells.
The aim of the present study is to propose the experimental context-specific quan-
titative indices of the autophagy activity based on the minimal autophagy model and
to apply the indices to the simulation-based analysis of the target autophagy system
(see Figure 2). Specifically, based on the minimal autophagy model [31], we recon-
struct underlying profiles of the autophagic process such as the time evolution of au-
tophagy fluxes, levels of autophagosomes/autolysosomes, and corresponding cellular
changes at good time resolution, from the biological experiments of the target au-
tophagy system [12-14,26,32,33]. Then, two quantitative indices measuring autophagy
activities in the induction of sequestration fluxes and in the selective degradation are
proposed from the model-driven profiles. Finally, the biological experiments are
interpreted with the help of the indices, not only to examine how the autophagy sys-
tem responds to cellular damaging but also to prove the causal relationships among
the steady-state autophagy levels, autophagic fluxes, and corresponding cellular
changes in a specific and quantitative manner. Developing such quantitative autoph-
agy indices from the minimal model will be highly challenging but indispensable for
the assessment of autophagy activity and of its roles associated with different physio-
pathological states.
Figure 2 Development of the experimental context-specific quantitative autophagy indices from
the minimal model. The workflow of the process is as follows: 1. Establishment of the minimal autophagy
model for the target autophagy system. 2. Reconstruction of underlying dynamics of the autophagic process at
good time resolution. 3. Introduction of two quantitative autophagy indices measuring autophagy activity
based on the model-driven autophagy profile. 4. Computer-aided analysis of the biological data with the help
of the indices. 5. Specific/quantitative interpretation and system-level understanding of the system.
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Model systems and simulations
We first outline briefly the minimal model used in developing quantitative indices of
the autophagy activity [31]. In this model, the multi-step autophagic process is di-
vided into autophagosome formation, autolysosome formation, and intralysosomal
hydrolysis steps, and the intracellular ATP and amino acids are considered to be the
key molecules serving as a bridge among the autophagic process, non-autophagic
degradation, and protein/organelle synthesis (see Figure 1). The dynamics of the
model system are described by eight coupled differential equations 1 to 6, which are
solved via the 5th order Runge–Kutta method for very high precision. Since the
present study is designed to analyze a specific autophagy mechanism rather than to
examine the general principle of autophagy, we have focused on the target autoph-
agy system in the parameter selection: The key parameters used in the simulations
have been fixed in accord with carefully selected biological data of the target au-
tophagy system [12-14,26,32-34]. A few adjustable parameters, which have been set
to reflect the experimental context, have minor influence on the simulations (see
Table 1).
Dynamic equations
In this model, variations of the autophagosome concentration with time are determined
by the difference between the autophagosome formation specific rate Rgi and the auto-
lysosome formation specific rate Rl. Denoting by Cgi the concentration of autophago-
somes originating from proteins/organelles Si, we write the equations for the dynamics
of autophagosomes in the form (i = 1, 2):
Table 1 Parameters in the model
Symbol Definition Unit Value Reference
r 0ð Þg Rate constant for autophagosome formation (normal value) s− 1 * 1.12 × 10− 5 [12], [13], [14]
kg Constant for autophagosome formation (ATP dependency) mM * 4.01 [12], [14]
pg Constant for autophagosome formation (ATP dependency) mM * 3.00 [12], [14]
ag Constant for autophagosome formation
(amino acids dependency)
mM 4.50
γg Constant for autophagosome formation
(amino acids dependency)
(unitless) * 1.22 [13]
ξg Constant for autophagosome formation
(amino acids dependency)
mM− 1 * 7.49 × 10− 2 [13]
rl Rate constant for autolysosome formation s
− 1 * 2.47 × 10− 5 [12], [14]
kl Constant for autolysosome formation (ATP dependency) mM * 4.01 [12], [14]
pl Constant for autolysosome formation (ATP dependency) mM * 3.00 [12], [14]
rh Rate constant for intralysosomal hydrolysis s
− 1 * 1.39 × 10− 5 [12], [14]
δh Exponent for intralysosomal hydrolysis (ATP dependency) (unitless) * 7.24 × 10− 1 [12], [14]
kh Constant for intralysosomal hydrolysis (ATP dependency) mM * 2.99 [12], [14]
rs Rate constant for protein/organelle synthesis mM ⋅ s
− 1 * 1.48 × 10− 5 [34]
ks Constant for protein/organelle synthesis
(amino acids dependency)
mM * 1.77 × 101 [34]
C mð ÞA ATP concentration corresponding to maximal
protein/organelle synthesis rate
mM 3.00
Parameters with asterisks (*) are fixed, determined from biological experiments [12-14,34]. Those without asterisks are
adjustable, depending on experimental setups.
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dt
¼ RgiCSi − RlCgi; ð1Þ
where CSi represents the concentration of Si. Next, the intracellular concentration Cli
of autolysosomes, originating from Si is determined by the difference between the auto-
lysosome formation specific rate Rl and the intralysosomal hydrolysis specific rate Rh.
The equations governing the dynamics thus read (i = 1, 2):
dCli
dt
¼ Rl t − τð Þ Cgi t − τð Þ − RhCli ð2Þ
Note that the autolysosome concentration at time t is affected by the autophagosomeconcentration at time t − τ, earlier by the delay time τ which is taken to be 8 minutes
(τ = 480 s) [26,32,33].
We have defined resident proteins/organelles S1 as the proteins and organelles which
conduct normal functions in the cell, and assumed that they are translated from normal
folding intermediates transcribed from DNA normally into RNA. On the other hand,
by abnormal proteins/organelles S2, we have meant the proteins and organelles which
conduct abnormal functions in the cell and assumed that they are made from two dis-
tinct sources: either from misfolded proteins and peptides, caused by genetic variants
and mutations or intracellular conditions, or from resident proteins and organelles,
damaged or aged by harmful conditions. Incorporating these, we have described the dy-
namics of S1 and of S2 by the evolution equations for the concentrations CS1 and CS2
of S1 and S2, respectively:
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dt
¼ 1 − αð ÞRS − Rd1 − βCS1 − Rg1CS1 ð3Þ
dCS2
dt
¼ αRS − Rd2 þ βCS1 − Rg2CS2; ð4Þ
where RS represents the (total) protein/organelle synthesis rate (from DNA) and α is
the fraction of S2 in the protein/organelle synthesis. Accordingly, S1 and S2 are pro-
duced at the rates of (1 − α)RS and αRS, respectively. Further, Rdi represents the non-
autophagic degradation rates of Si (for i = 1, 2) and β is the specific rate of deterioration
of S1, i.e., transformation from S1 to S2.
The dynamics of intracellular amino acids, the concentration of which is denoted by









Rdi þ Ra − μsRS; ð5Þ
of which the first and second term on the right-hand side correspond to the increase of
amino acids due to intralysosomal hydrolysis and nonautophagic protein/organelle deg-
radation, respectively, with appropriate constants μa and μd describing the mean num-
bers of amino acids produced from autophagic degradation and from non-autophagic
degradation, respectively. The third term represents the net intracellular amino acid
generation rate due to various intracellular metabolisms other than autophagy, and has
been defined according to Ra = μcRS with an appropriate constant μc. The last term stands
for the reduction of amino acids due to protein/organelle synthesis, with the constant μs
denoting the mean number of amino acids within a protein/organelle.
It has been assumed that the intracellular ATP concentration CA increases due to
intralysosomal hydrolysis and non-autophagic protein/organelle degradation via cytosolic









Rdi þ RA − νsRS; ð6Þ
where νa and νd describe the mean numbers of ATP molecules produced from autoph-
agic degradation and from non-autophagic degradation, respectively, and νs gives the
mean number of ATP molecules consumed in unit protein/organelle synthesis. The net
intracellular ATP generation rate RA is given by the difference between the cytosolic
and mitochondrial ATP production rate and the ATP consumption rate, and is as-
sumed to be RA = νcRS with a constant νc.
For simplicity, we have supposed that an average protein/organelle in the virtual cel-
lular system is composed of 500 amino acid residues, implying that 500 amino acids
are consumed for the synthesis of a protein/organelle. Further, considering the fact that
elongation of one amino acid during translation requires approximately four ATP mol-
ecules, we have assumed 2000 molecules of ATP involved in the synthesis of a protein/
organelle. However, since the efficacy of protein/organelle recycling is expected to be
less than 100%, the increases of amino acids and ATP due to intralysosomal hydrolysis
or non-autophagic protein/organelle degradation should be less than 500 and 2000
molecules per degradation of one protein/organelle, respectively. In this study, we have
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500, and νs = 2000.Results
Quantitative indices from minimal models
Solving Eqs. 3 and 4, we have obtained the time evolution of concentrations CS1 and
CS2 of resident S1 and abnormal proteins/organelles S2, respectively (see Figure 3). They
display oscillations with the period of 12 h 55 min (or the natural frequency 0.0774 h‐ 1)
[35-39], with CS1 and CS2 of the average values of CS1 and CS2 given by 8.57 mM and
2.52 mM, respectively.
Based on such model-driven profiles of intracellular concentrations of proteins/ or-
ganelles, we propose the fractional abnormal protein/organelle concentration fc as a
simple index of the cellular protein/organelle quality [40]:
f c≡
CS2
CS1 þ CS2 ; ð7Þ
which takes values between 0 and 1: While the value fc ≈ 0 addresses that most of the
proteins/organelles in the system are normal, fc ≈ 1 indicates that the majority of the
proteins/organelles are damaged.Figure 3 Time evolution of the protein/organelle concentrations. Red solid and blue dotted lines
describe the time evolution of the concentrations CS1 (top) and CS2 (bottom) of resident and abnormal
proteins/organelles, respectively. Data have been obtained at rg ¼ r 0ð Þg and β = β(0).
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somes from S1 and from S2, respectively (left axis), and the time evolution of concen-
trations Cl1 and Cl2 of autolysosomes from S1 and from S2, respectively (right axis).
It has turned out that they display oscillations with the period of 12 h 55 min (or the
natural frequency 0.0774 h‐ 1) in the absence of external driving [41-48]. The percentile
ratios of the peak-to-peak amplitudes to the mean levels of the oscillations are 0.929%
for Cg1, 0.0676% for Cg2, and 20.8% for Cl1 and for Cl2, with negligibly small standard
deviations (of the order 10−5 relative to the amplitudes). Note here that the oscillation
amplitudes of autophagosome concentrations are far smaller than those of autolyso-
some concentrations. The average concentrations Cg1 and Cg2 turned out to be
0.0589 mM and 1.90 mM, respectively and those of autolysosomes, Cl1 and Cl2, to be
0.0156 mM and 0.503 mM, respectively.
Furthermore, the minimal autophagy model allows us to characterize quantitatively
the relationship between the autophagy activity and the cellular change, based on the
system-level understanding of the autophagic process at good time resolution, which
may not be possible via the current in vivo and in vitro measurements. For example,
from the model-driven profiles of the steady-state concentrations of autophagic inter-
mediates (Figure 4), together with the dynamics of proteins/organelles (Figure 3),Figure 4 Time evolution of the autophagosome and autolysosome concentrations. Red solid and
blue dotted lines describe the time evolution of the autophagosome concentrations Cg1 and Cg2 and
autolysosome concentrations Cl1 and Cl2, respectively, transformed from S1 (top panel) and from S2
(bottom panel). Data have been obtained under the condition rg ¼ r 0ð Þg and β = 0.2 %/h≡ β(0).
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differences between the production rates of autophagosomes/autolysosomes from resi-
dent proteins/organelles and those from abnormal proteins/organelles: The steady-state
concentration ratio of Cl1 to CS1 is given by 0.00182 whereas that of Cl2 to CS2 is 0.200.
In addition, the ratios of Cg1 to CS1 and of Cg2 to CS2 read 0.00687 and 0.754, respectively.
For a more specific and quantitative analysis of various facets of the substrate selectivity
of autophagy [40,49-54], we here propose a quantitative index of the autophagy selectivity
(see Figure 1).
The autophagy selectivity index ΦS, which is designed to quantify the selective au-








where Cli denotes the average concentration of autolysosomes from Si(i = 1, 2). Note
that positive values of ΦS imply that autophagic degradation of S2 exceeds that of S1
whereas negative values correspond to the degradation of S1 exceeding that of S2.
This model allows us to reconstruct not only the dynamics of the steady-state con-
centrations of autophagosomes/autolysosomes but also the time evolution of autophagy
fluxes. As shown in Figure 5, fluxes of sequestration, of maturation, and of intralysoso-
mal hydrolysis from S2, denoted by Fs2, Fm2, and Fh2, respectively, and those from S1,
denoted by Fs1, Fm1, and Fh1, display synchronized oscillations. Note also that the values
of fluxes from S2 are much greater than those from S1.
Based on such comprehensive information as to the kinetics of the process obtained
from the minimal model, we propose the autophagy induction index ΦI, which is de-
vised to measure the induction of the total sequestration flux coming from both resi-
dent proteins/organelles S1 and abnormal proteins/organelles S2:
ΦI≡ F s1 þ F s2; ð9Þ
where F Si denotes the average sequestration flux for Si(i = 1, 2).
Quantitative analysis through the use of autophagy indices
To determine whether the indices given in the previous section are useful for the spe-
cific and quantitative assessment of the autophagy pathway and for the system-level un-
derstanding of the process, we in this section apply the indices to the interpretation of
the target autophagy system, metabolically controlled autophagic protein/organelle deg-
radation in the rat hepatocyte [12-14,26,32,33]. To be specific, we conduct the
simulation-based analysis of how the autophagic process responds to cellular damaging
and prove the causal relationships among the steady-state autophagy levels, autophagic
fluxes, and corresponding cellular changes with the help of the indices.
It is shown in Figure 6 that ΦI grows drastically with the (specific) deterioration rate
β until the value β ≈ 0.12, which illustrates autophagy induced against the cellular dam-
aging rate. As β is raised beyond the value β ≈ 0.12, ΦI increases gradually and displays
a plateau. On the other hand, as β is increased from zero, ΦS stays at relatively high
positive values until β ≈ 0.12, beyond which it reduces gradually.
Therefore, both the non-selective mode of sequestration fluxes (represented by ΦI)
and the selective mode of the autophagic degradation of abnormal proteins/organelles
Figure 5 Autophagic fluxes in sequestration, maturation, and intralysosomal hydrolysis. Red solid,
blue dotted, green dashed lines describe the time evolution of sequestration fluxes Fs1 and Fs2, maturation
fluxes Fm1 and Fm2, and intralysosomal hydrolysis fluxes Fh1 and Fh2, respectively, originating from S1 (top)
and from S2 (bottom). Data have been obtained at rg ¼ r 0ð Þg and β = β(0).
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help of the indices: The increasing behavior of ΦI with the deterioration rate β suggests
that the total sequestration flux coming from both resident and abnormal proteins/or-
ganelles is induced, resisting against the cellular damaging level. In addition, the posi-
tive values of ΦS in the range of β from 0 to 0.5 (%/h) indicates that abnormal
proteins/organelles are selectively removed via autophagy.
We then analyze how the promotion or suppression of autophagy affects the cellular
quality control. Figure 7 exhibits the fractional abnormal protein/organelle concentra-
tion fc depending on the autophagy indices ΦI and ΦS, in response to varying the rate
constant rg for autophagosome formation in Eqs. A1 and A2 in Appendix A. Data have
been obtained at the specific deterioration rate β = 0.2(%/h) ≡ β(0), where the resident
protein/organelle synthesis rate is approximately equal to the abnormal one.
In the case of no autophagic flux in the system (ΦI = 0), the fractional concentration
is positioned at a very high level ((fc ≈ 1), indicating that most of the proteins/organelles
in the system are damaged (top panel). As autophagosome formation is promoted,
namely, as rg is increased, however, ΦI begins to increase. In particular, the abrupt increase
in ΦI at rg ¼ r 1ð Þg ≈ 0:03, together with the drop in fc at the same rate constant, appears
here as the apparently discontinuous change in fc at the values between ΦI ≈ 0 and ΦI ≈ 2.
Figure 6 Autophagy induction index ΦI (red pluses) and selectivity index ΦS (blue asterisks) versus
the specific deterioration rate β. Data have been obtained at rg ¼ r 0ð Þg with β varied up to 0.5 (%/h).
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zero.
In addition, fc varies also inversely proportional to ΦS. In case that the autophagic
degradation of resident protein/organelle is larger than that of abnormal protein/organelle
(ΦS < 0), fc stays at an abnormally high level (fc ≈ 1), namely, most of the proteins/organ-
elles in the system are damaged (bottom panel). As ΦS is increased slightly above zero,
there arises a discontinuous drop via which fc becomes restored quickly to the normal
level. As ΦS is raised further and approaches unity, fc keeps decreasing toward zero.
Discussion
The minimal model for autophagy was originally developed to examine the dynamics
of the autophagic process, describing specifically the rates at which autophagosome
and autolysosome concentrations vary with time [31]. Based on the model, we have re-
constructed underlying profiles of the autophagy process such as the time evolution of
autophagy fluxes, levels of autophagosomes/autolysosomes, and corresponding cellular
changes from the target autophagy system, in which the corresponding biological ex-
periments [12-14,26,32,33] provide information only as to the changes before and after
certain experimental perturbations on specific processes. We have then proposed quan-
titative indices of the autophagic process, and used them to analyze how the autophagic
degradation compensates cellular damaging. Emphasis has been paid on the stressful
conditions, specifically, at extremely high rates of protein/organelle deterioration. As
discussed in Figures 6 and 7, indices ΦI and ΦS have successfully characterized the
non-selective induction rate of autophagy and selective intralysosomal hydrolysis, respect-
ively, in the presence of physiological perturbations such as variations of the cellular dam-
aging rate and promotion or suppression of autophagosome formation. Furthermore, as
shown in Figure 7, fc reduces sensitively as ΦI or ΦS is increased; this might be inferred
Figure 7 Fractional protein/organelle concentration fc versus autophagy indices ΦI and ΦS. Data
plotted with filled purple rhombi (top panel) and open blue rhombi (bottom panel) have been obtained
via suppressing or promoting autophagosome formation at β = β(0). The rate constant has been raised from
rg = 0 to rg = 10 at the increment of 0.01 (in units of r
0ð Þ
g ).
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and the improvement of substrate selectivity in the autophagic degradation, described by
ΦS, are beneficial for the control and regulation of the cellular protein/organelle quality,
measured by fc. On the other hand, these results may disclose the roles of evolutionary-
conserved basal autophagy in cell survival. Under extremely low levels of autophagic flux,
the system may lose its ability to control the cellular protein/organelle quality, eventually
resulting in cell death: As rg is reduced below r
1ð Þ
g ≈0:03, the fractional concentration fc re-
mains at an abnormally high level, which may cause dysfunctions of the cell (Figure 7).
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1ð Þ
g , normal cellular functions might
not be recovered; this appears to be supported by the accompanying behaviors of resident
and abnormal proteins/organelles as well as of autolysosomes, amino acids, and ATP
(data not shown). Furthermore, in the case of no autophagic flux in the system as illus-
trated for rg = 0, most of the proteins/organelles in the system are damaged (fc ≈ 1), with
the corresponding indices given by ΦI = 0 and ΦS < 0 (see Figure 7).
As the practical applications of this theoretical study, we remark implications of the
quantitative autophagy indices for the development of a novel strategy for the assess-
ment of autophagy. Several biochemical assays such as the measurement of autophagic
sequestration [22], detection of the turnover of specific autophagic compartments or
autophagy-related markers [23-25], and quantification of the autophagic protein/organ-
elle degradation [55] have recently been suggested to provide indirect correlative data
relating to the autophagic protein/organelle quality control. However, there still lacks
full biochemical or molecular understanding of what distinguishes the selective and
nonselective autophagic modes and how context- and activation-degree-dependency of
selective/nonselective autophagy contributes to the protein/organelle quality control.
Further, there are no absolute criteria, applicable to diverse situations, for determining
the autophagic flux, mainly because some techniques and chemicals in certain assays
are inappropriate, problematic, or may not work at all in other assays. Namely, it is not
yet known whether the measurement of LC3-IIs/LC3-I and p62/SQSTM1 is generally
applicable to other cell types, for changes in LC3-II or p62 amounts are tissue- and cell
context-dependent; this constitutes the main caveat regarding the method. Also, the
GFP-LC3 processing assay appears to depend on cell types and culture conditions,
which is the main limitation. Even in the same assay, when using those techniques and
chemicals, it is critical to consider the tissue- and cell context-dependent effects. In-
deed, in some cases, the amounts of those indirect markers may not correlate well with
the autophagosome/autolysosome accumulation detected by electron microscopy which
is the most reliable criterion for autophagy activity.
In these circumstances, it is very desirable to have quantitative indices together with
the appropriate mathematical model, which make it possible to provide a set of reliable
criteria for the definition of the autophagy activation and further the assessment of its
roles associated with different physiopathological states. Furthermore, the quantitative
indices of the autophagy activation could give kinetic information as to the autophagic
process, i.e., autophagosome formation, autolysosome formation, and intralysosomal
hydrolysis. With such parameters available quantitatively, the worth of those conven-
tional approaches to assessing autophagic fluxes or steady-state quantities of autopha-
gosomes or autolysosomes could be greatly enhanced [27,56-61].
It is also to be noted that the proposed indices ΦI and ΦS are designed based on the
selective profiles of autophagy, i.e., autophagic intermediates/fluxes from S1 and those
from S2. Further, the indices can be modified depending on the experimental settings,
with which selective autophagy is associated [40,49-54]: In fact, S1 and S2 in this study
can denote different proteins/organelles in specific diseases such as ‘aging’, ‘intracellular
quality control and housekeeping’, and ‘host defense against intracellular pathogens’.
Accordingly, the indices should be easily applicable to various biochemical [20-25] and
morphological [26-30] experiments, which selectively detect and quantify autophagy ac-
tivity depending on their target substrates. Although such selective measurement of the
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assay techniques [27,56,57], the indices should be useful in getting a better grasp of the
substrate-selective autophagy activity and its role, complementing current biological
techniques [20-30,55-57].
Conclusion
We have proposed quantitative autophagy indices, based on the mathematical model,
to define autophagy activity and further assess its role. With the help of the indices in
conjunction with the computer-aided analysis, we have characterized quantitatively the
cause-and-effect relationship among the steady-state autophagy levels, autophagic
fluxes, and corresponding cellular changes in response to various physiological pertur-
bations, which may not be probed via biological assays.
Our study acts as a natural link between experimental and computational/theoretical
biology. Such an integrative approach should possibly lead to a comprehensive under-
standing of the control and/or regulatory mechanism of autophagy and reduce ambigu-
ity as to causes and effects in the complex autophagy system. From a medical
viewpoint, it should provide us new insight into the role of autophagy in various human
diseases, including cancer, metabolic disorders, and neurodegenerative diseases and fur-
ther help to develop new drugs or treatment methods which target specific autophagy
pathways [16-19]. We hope to develop more realistic model-based quantitative indices
of autophagy activity and new methods of monitoring autophagy, complementing re-
cent biochemical assays; this is left for further study.
Appendix A
Autophagosome formation
Under normal conditions, it appears that abnormal proteins/organelles degrade preferen-
tially via basal autophagy [49-52]. As the intracellular energy/nutrient reduces due to, e.g.,
starvation or increased metabolic demand, however, both resident and abnormal pro-
teins/organelles are degraded non-selectively by bulk autophagy for the rapid supply of
the essential energy/metabolite molecules. Therefore, it is assumed in this model that the
autophagosome formation rate from resident proteins/organelles, which is lower than that
from abnormal proteins/organelles under normal conditions, becomes gradually equal to
that from abnormal proteins/organelles as the amino acid concentration is decreased
[5,11,62,63]. Note, however, that the molecular mechanism of these steps is not included
since the mechanism, via which ATP and amino acids control autophagosome formation,
is relatively poorly understood. For example, preliminary studies show merely that amino
acids regulate the LC3 level at the mRNA expression level [64]. Instead, we have obtained
the dependence of these steps on intracellular ATP and amino acid concentrations, based
on physiological-level experiments [12-14] (see Figure 1).
In consequence, we thus take the autophagosome formation specific rates Rg1 (from resi-
dent proteins/organelles S1) and Rg2 (from abnormal proteins/organelles S2) as functions of
the intracellular concentrations CA of ATP [12,14] and Ca of amino acids [13] in the
form:
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g is the rate constant for autophagosome formation, with appropriate constants
kg, pg (for ATP), ag, γg, and ξg (for amino acids). In our simulations, the basal level of
autophagy is suppressed or promoted by adjusting the value of rg (in units of the nor-
mal value r 0ð Þg ) (see Table 1).
Autolysosome formation
We next consider the autolysosome formation step, which consists of multiple fusions
with lysosomes, which provide an acidic environment and a digestive function to the
interior of the autophagosome [65,66]. In view of the experimental demonstration that
the dynamics of autophagosome maturation depends on whether the ATP supply is on
or off, we incorporate the intracellular ATP dependence of the step, and take the spe-
cific rate Rl in the form [12,14]:







where rl denotes the rate constant for autolysosome formation, with appropriate con-
stants kl and pl for ATP. Note here that the possible difference between the maturation
rates of autophagosomes from proteins/organelles S1 and S2 [51,53], which relatively
lacks proven molecular mechanism, has not been considered in this model. Although
extensive characterization of ATG genes has yielded critical insight into the mechanism
of autophagy activation and its flux, so far whether and how the selective fusion of
autophagosomes to lysosomes is controlled remain poorly elucidated [50,51,54,67-70].
Intralysosomal hydrolysis
The ATP dependency of the intralysosomal hydrolysis step, which displays relatively
low sensitivity to the ATP concentration change compared with the autophagosome
formation step, is incorporated. In accord with experiment [12,14], the intralysosomal
hydrolysis specific rate Rh is taken as a function of the intracellular ATP concentration:




with appropriate exponent δh and constant kh for ATP, where rh is the rate constant for
intralysosomal hydrolysis. Considering that there is little experimental evidence about
the selective intralysosomal hydrolysis, we assume that the intralysosomal hydrolysis
rates for autolysosomes originated from both S1 and S2 are the same.
Protein synthesis and non-lysosomal degradation
In addition to the autophagic process, we incorporate the (total) protein synthesis rate
RS, depending on the amino acid concentration Ca, in agreement with experiment [34].
Assuming that the rate grows exponentially with the intracellular ATP concentration
CA increased to the steady-state value, we write the protein synthesis rate in the form:
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with appropriate constant ks for amino acid, where C
mð Þ
A is the ATP concentration cor-
responding to the maximal protein/organelle synthesis rate and rs denotes the rate con-
stant for the protein/organelle synthesis.
Further, non-autophagic degradation machinery such as the ubiquitin-proteasome
system has been considered in the model. We suppose that the amount of protein deg-
radation by autophagy constitutes up to 80% of the total amount of protein degradation
[71]. Taking the rate of non-autophagic degradation to be 25% of autophagic degrad-
ation, we have the rate of non–autophagic degradation (i = 1, 2):
Rdi ¼ 14RhCli: ðA6Þ
where Cli denotes the concentration of autolysosomes from Si.
Abbreviations
ATP: Adenosine triphosphate; DNA: Deoxyribonucleic acid; RNA: Ribonucleic acid; mRNA: Messenger RNA;
Atg: Autophagy-related gene; LC3: Microtubule-associated protein 1A/1B light chain 3A; LC3-II: LC3-
phosphatidylethanolamine conjugate; LC3-IIs: Soluble form of LC3-II; GFP: Green fluorescent protein; GFP-LC3: GFP
tagged LC3; p62: Nuclear pore complex (nucleoporins) p62; SQSTM1: Sequestosome 1.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KH designed the mathematical model, performed the simulations, analyzed the data, and wrote the manuscript.
JK conceived of the study, participated in its design and coordination, and analyzed the data. MYC supervised the
research, wrote the manuscript, designed the mathematical model, and analyzed the data. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by the National Research Foundation of Korea through the Basic Science Research Program
(Grant Nos. 2012R1A2A4A01004419, 2011–0012331, and 2010–0023855).
Received: 1 May 2014 Accepted: 30 June 2014
Published: 6 July 2014
References
1. Klionsky DJ, Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717–1721.
2. Rabinowitz JD, White E: Autophagy and Metabolism. Science 2010, 330:1344–1348.
3. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, Tanaka K, Cuervo AM, Czaja MJ: Autophagy regulates
lipid metabolism. Nature 2009, 458:1131–1135.
4. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K: Loss of
autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880–884.
5. Kuma A, Mizushima N: Physiological role of autophagy as an intracellular recycling system: With an emphasis
on nutrient metabolism. Semin Cell Dev Biol 2010, 21:683–690.
6. Onodera J, Ohsumi Y: Autophagy is required for maintenance of amino acid levels and protein synthesis
under nitrogen starvation. J Biol Chem 2005, 280:31582–31586.
7. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB: Growth factor regulation of autophagy
and cell survival in the absence of apoptosis. Cell 2005, 120:237–248.
8. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N: The role
of autophagy during the early neonatal starvation period. Nature 2004, 432:1032–1036.
9. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL,
Slingerland JM, Mills GB: The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation
mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007, 9:218–224.
10. Hardie DG: AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function.
Genes Dev 2011, 25:1895–1908.
11. Mortimore GE, Poso AR: Intracellular protein catabolism and its control during nutrient deprivation and
supply. Annu Rev Nutr 1987, 7:539–564.
12. Plomp PJ, Gordon PB, Meijer AJ, Høyvik H, Seglen PO: Energy dependence of different steps in the autophagic-
lysosomal Pathway. J Biol Chem 1989, 264:6699–6704.
Han et al. Theoretical Biology and Medical Modelling 2014, 11:31 Page 17 of 18
http://www.tbiomed.com/content/11/1/3113. Seglen PO, Gordon PB: Amino acid control of autophagic sequestration and protein degradation in isolated
rat hepatocytes. J Cell Biol 1984, 99:435–444.
14. Plomp PJ, Wolvetang EJ, Groen AK, Meijer AJ, Gordon PB, Seglen PO: Energy dependence of autophagic protein
degradation in isolated rat hepatocytes. Eur J Biochem 1987, 164:197–203.
15. Rosenfeldt MT, Ryan KM: The role of autophagy in tumor development and cancer therapy. Expert Rev Mol Med
2009, 11:e36.
16. Mizushima N,B, Levine B, Cuervo AM, Klionsky DJ: Autophagy fights disease through cellular self-digestion.
Nature 2008, 451:1069–1075.
17. Levine B, Kroemer G: Autophagy in the pathogenesis of disease. Cell 2008, 132:27–42.
18. Li X, Xu HL, Liu YX, An N, Zhao S, Bao JK: Autophagy modulation as a target for anticancer drug discovery.
Acta Pharmacol Sin 2013, 34:612–624.
19. Dai JP, Li WZ, Zhao XF, Wang GF, Yang JC, Zhang L, Chen XX, Xu YX, Li KS: A Drug Screening Method Based on the
Autophagy Pathway and Studies of the Mechanism of Evodiamine against Influenza A Virus. PLoS ONE 2012, 7:e42706.
20. Kadowaki M, Karim MR: Cytosolic LC3 ratio as a quantitative index of macroautophagy. Methods Enzymol 2009,
452:199–213.
21. Sheen JH, Zoncu R, Kim D, Sabatini DM: Defective regulation of autophagy upon leucine deprivation reveals a
targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 2011, 19:613–628.
22. Seglen PO, Øverbye A, Sætre F: Sequestration assays for mammalian autophagy. Methods Enzymol 2009, 452:63–83.
23. Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E: Lysosomal turnover, but not a cellular level, of endogenous
LC3 is a marker for autophagy. Autophagy 2005, 1:84–91.
24. Kimura S, Fujita N, Noda T, Yoshimori T: Monitoring autophagy in mammalian cultured cells through the
dynamics of LC3. Methods Enzymol 2009, 452:1–12.
25. Mizushima N, Yoshimori T: How to interpret LC3 immunoblotting. Autophagy 2009, 3:542–545.
26. Schwörer CM, Shiffer KA, Mortimore GE: Quantitative relationship between autophagy and proteolysis during
graded amino acid deprivation in perfused rat liver. J Biol Chem 1981, 256:7652–7658.
27. Klionsky DJ, Cuervo AM, Seglen PO: Methods for monitoring autophagy from yeast to human. Autophagy 2007,
3:181–206.
28. Mizyshima N: Methods for monitoring autophagy. Int J Biochem Cell Biol 2004, 36:2491–2502.
29. Kawai A, Takano S, Nakamura N, Ohkuma S: Quantitative monitoring of autophagic degradation. Biochem
Biophys Res Commun 2006, 351:71–77.
30. Ma XH, Piao S, Wang D, McAfee QW, Nathanson KL, Lum JJ, Li LZ, Amaravadi RK: Measurements of tumor cell
autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res 2011,
17:3478–3489.
31. Han K, Kwon H, Kang H, Kim J, Lee MS, Choi MY: Dynamics of macroautophagy: Modeling and oscillatory
behavior. Physica A 2012, 391:686–692.
32. Kovács J, Fellinger E, Kárpáti AP, Kovács AL, László L, Réz G: Morphometric evaluation of the turnover of autophagic
vacuoles after treatment with Triton X-100 and vinblastine in murine pancreatic acinar and seminal vesicle
epithelial cells. Virchows Arch B 1987, 53:183–190.
33. Pfeifer U: Inhibition by insulin of the formation of autophagic vacuoles in rat liver. A morphometric approach
to the kinetics of intracellular degradation by autophagy. J Cell Biol 1978, 78:152–167.
34. Seglen PO, Solhem AE: Effects of aminooxyacetate, alanine and other amino acid on protein synthesis in
isolated rat hepatocytes. Biochim Biophys Acta 1978, 520:630–641.
35. Liu JH, Lindsey JD, Weinreb RN: Physiological factors in the circadian rhythm of protein concentration in
aqueous humor. Invest Ophthalmol Vis Sci 1998, 39:553–558.
36. Brodsky VY, Zvezdina ND, Fateeva VI, Mal'chenko LA: Involvement of protein kinases in self-organization of the
rhythm of protein synthesis by direct cell-cell communication. Cell Biol Int 2007, 31:65–73.
37. Brodsky VY, Dubovaya ND, Zvezdina ND, Fateeva VI, Mal'chenko LA: Melatonin modifies the rhythm of protein
synthesis. Bull Exp Biol Med 2010, 149:40–43.
38. Brodsky VY, Zvezdina ND: Melatonin as the most effective organizer of the rhythm of protein synthesis in
hepatocytes in vitro and in vivo. Cell Biol Int 2010, 34:1199–1204.
39. Brodsky VY, Boikov PY, Nechaeva NV, Yurovitsky YG, Novikova TE, Fateeva VI, Shevchenko NA: The rhythm of
protein synthesis does not depend on oscillations of ATP level. J Cell Sci 1992, 103:363–370.
40. Han K, Kim J, Choi MY: Computer simulations unveil the dynamics of autophagy and its implications for the
cellular quality control. J Biol Syst. in press.
41. Ma D, Panda S, Lin JD: Temporal orchestration of circadian autophagy rhythm by C/EBPβ. EMBO J 2011, 30:4642–4651.
42. Pfeifer U, Scheller H: A morphometric study of cellular autophagy including diurnal variations in kidney
tubules of normal rats. J Cell Biol 1975, 64:608–621.
43. Pfeifer U, Strauss P: Autophagic vacuoles in heart muscle and liver. A comparative morhometric study
including circadian variations in meal-fed rats. J Mol Cell Cardiol 1981, 13:37–49.
44. Remé CE, Sulser M: Diurnal variation of autophagy in rod visual cells in the rat. Albrecht Von Graefes Arch Klin
Exp Ophthalmol 1977, 203:261–270.
45. Pfeifer U: Cellular autophagy and cell atrophy in the rat liver during long-term starvation. A quantitative
morphological study with regard to diurnal variations. Virchows Arch B Cell Pathol 1973, 12:195–211.
46. Sachdeva UM, Thompson CB: Diurnal rhythms of autophagy: Implications for cellbiology and human disease.
Autophagy 2008, 4:581–589.
47. Pfeifer U: Inverted diurnal rhythm of cellular autophagy in liver cells of rats fed asingle daily meal. Virchows
Arch B Cell Pathol 1972, 10:1–3.
48. Pfeifer U, Bertling J: A morphometric study of the inhibition of autophagic degradation during restorative
growth of liver cells in rats re-fed after starvation. Virchows Arch B Cell Pathol 1977, 24:109–120.
49. Kraft C, Peter M, Hofmann K: Selective autophagy: ubiquitin-mediated recognition and beyond. Nat Cell Biol
2010, 12:836–841.
Han et al. Theoretical Biology and Medical Modelling 2014, 11:31 Page 18 of 18
http://www.tbiomed.com/content/11/1/3150. Johansen T, Lamark T: Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279–296.
51. Lee JY, Yao TP: Quality control autophagy. A joint effort of ubiquitin, protein deacetylase and actin
cytoskeleton. Autophagy 2010, 6:555–557.
52. Behrends C, Fulda S: Receptor proteins in selective autophagy. Int J Cell Biol 2012, 2012:673290.
53. Lee JY, Koga H, Kawaguchi Y, Tang W, Wong E, Gao YS, Pandey UB, Kaushik S, Tresse E, Lu J, Taylor JP, Cuervo AM,
Yao TP: HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy.
EMBO J 2010, 29:969–980.
54. Kirkin V, McEwan DG, Novak I, Dikic I: A role for ubiquitin in selective autophagy. Mol Cell 2009, 34:259–269.
55. Bauvy C, Meijer AJ, Codogno P: Assaying of autophagic protein degradation. Methods Enzymol 2009, 452:47–61.
56. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P,
Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, Al-Younes HM, Al-Zeer MA, Albert ML,
Albin RL, Alegre Abarrategui J, Aleo MF, Alirezaei M, Almasan A, Almonte-Becerril M, Amano A, Amaravadi R,
Amarnath S, Amer AO, Andrieu-Abadie N, Anantharam V, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy. Autophagy 2012, 8:445–544.
57. Mizushima N, Yoshimori T, Levine B: Methods in mammalian autophagy research. Cell 2010, 140:313–326.
58. Changou CA, Wolfson DL, Ahluwalia BS, Bold RJ, Kung HJ, Chuang FY: Quantitative Analysis of Autophagy using
Advanced 3D Fluorescence Microscopy. J Vis Exp 2013, 75:e50047.
59. Phadwal K, Alegre-Abarrategui J, Watson AS, Pike L, Anbalagan S, Hammond EM, Wade-Martins R, McMichael A,
Klenerman P, Simon AK: A novel method for autophagy detection in primary cells: Impaired levels of
macroautophagy in immunosenescent T cells. Autophagy 2012, 8:677–689.
60. Dennis PB, Mercer CA: The GST-BHMT assay and related assays for autophagy. Methods Enzymol 2009, 452:97–118.
61. Ueno T, Ishidoh K, Mineki R, Tanida I, Murayama K, Kadowaki M, Kominami E: Autolysosomal membrane-
associated betaine homocysteine methyltransferase. Limited degradation fragment of a sequestered cyto-
solic enzyme monitoring autophagy. J Biol Chem 1999, 274:15222–15229.
62. Yoshimori T: Autophagy: A regulated bulk degradation process inside cells. Biochem Biophys Res Commun 2004,
313:453–458.
63. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y: In vivo analysis of autophagy in response to
nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004,
15:1101–1111.
64. Kadowaki M, Karim MR, Carpi A, Miotto G: Nutrient control of macroautophagy in mammalian cells. Mol Aspects
Med 2006, 27:426–443.
65. Klionsky DJ: Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol
Cell Bio 2007, 8:931–937.
66. Eskelinen EL: Maturation of autophagic vacuoles in mammalian cells. Autophagy 2005, 1:1–10.
67. Nara A, Mizushima N, Yamamoto A, Kabeya Y, Ohsumi Y, Yoshimori T: SKD1 AAA ATPase-dependent endosomal
transport is involved in autolysosome formation. Cell Struct Funct 2002, 27:29–37.
68. Kimura S, Noda T, Yoshimori T: Dissection of the autophagosome maturation process by a novel reporter
protein, tandem fluorescent-tagged LC3. Autophagy 2007, 3:452–460.
69. Jäger S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen EL: Role for Rab7 in maturation of late
autophagic vacuoles. J Cell Sci 2004, 117:4837–4848.
70. Itakura E, Kishi-Itakura C, Mizushima N: The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes
for fusion with endosomes/lysosomes. Cell 2012, 151:1256–1269.
71. Seglen PO, Bohley P: Autophagy and other vacuolar protein degradation mechanisms. Experientia 1992,
48:158–172.doi:10.1186/1742-4682-11-31
Cite this article as: Han et al.: Quantitative indices of autophagy activity from minimal models. Theoretical Biology
and Medical Modelling 2014 11:31.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
